The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-(1-methyl-1H-pyrazol-4-yl)benzyl)-4-(3-(trifluoromethyl)phenyl)-1H-1,2,3-triazole ID: ALA4476000
PubChem CID: 151428103
Max Phase: Preclinical
Molecular Formula: C20H16F3N5
Molecular Weight: 383.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(-c2ccc(Cn3cc(-c4cccc(C(F)(F)F)c4)nn3)cc2)cn1
Standard InChI: InChI=1S/C20H16F3N5/c1-27-12-17(10-24-27)15-7-5-14(6-8-15)11-28-13-19(25-26-28)16-3-2-4-18(9-16)20(21,22)23/h2-10,12-13H,11H2,1H3
Standard InChI Key: PBYFXEFTMBEMLE-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
16.2171 -23.6386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9236 -24.0475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6293 -23.6369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6266 -22.8189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9124 -22.4131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2097 -22.8260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3323 -22.4067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0425 -22.8082 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0462 -23.6288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8279 -23.8790 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3073 -23.2128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8219 -22.5511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1245 -23.2091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5325 -23.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3489 -23.9131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7551 -23.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3389 -22.4948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5238 -22.5017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5118 -24.8720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5109 -24.0499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7287 -23.7965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2461 -24.4622 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7301 -25.1268 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4289 -24.4631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7417 -21.7839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5589 -21.7773 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.3274 -21.0795 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.1455 -21.0736 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 8 1 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 1 0
23 19 2 0
22 24 1 0
17 25 1 0
25 26 1 0
25 27 1 0
25 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.38Molecular Weight (Monoisotopic): 383.1358AlogP: 4.41#Rotatable Bonds: 4Polar Surface Area: 48.53Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.83CX LogP: 4.73CX LogD: 4.73Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -2.15
References 1. Shan Y, Si R, Wang J, Zhang Q, Zhou H, Song J, Zhang J, Chen Q.. (2019) Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs., 164 [PMID:30616052 ] [10.1016/j.ejmech.2018.12.067 ]